About HeartVista
Vista AI develops intelligent software to streamline and automate MRI examinations, making gold-standard imaging universally accessible. The company's flagship product, Vista AI Scan, is an FDA-cleared automated scanning platform that simplifies the image acquisition process, enabling technologists of all skill levels to perform accurate, high-quality cardiac MRI scans with consistency and efficiency. The platform addresses critical challenges facing imaging programs including rising demand, staffing shortages, and increasing clinical complexity. By automating what once required specialist expertise, Vista AI enables healthcare organizations to expand cardiac MRI services across multiple sites with existing staff and resources. The technology has demonstrated real-world results including 26% faster scan times, 50% more scan slots, and reduction of scan backlogs from 28 days to 1-day access. While initially focused on cardiac MRI—the most complex anatomy to image—Vista AI is rapidly expanding its automation platform to other anatomies including brain, prostate, and spine imaging. The company's vision is to make gold-standard MRI universally available through automation, ensuring every patient has access to high-quality imaging regardless of location or technologist expertise. Founded by Stanford-trained experts and guided by leading medical advisors, Vista AI serves health systems, imaging centers, and hospitals seeking to improve throughput, standardize quality, and expand access to advanced MRI services.
Mission & Story
Mission
Our vision is to make gold-standard MRI universally available through automation—starting with cardiac imaging. Because every patient deserves access to gold-standard imaging, no matter where they are or who's behind the scanner.
Founding Story
Vista AI was founded by Dr. Bill Overall, PhD, Dr. Juan Santos, PhD, and Dr. Bob Hu, MD, who trained at Stanford's MRSRL (Magnetic Resonance Systems Research Lab). Since 2012, the team has worked with top imaging experts, scanned thousands of patients, and refined their algorithms to develop FDA-cleared automated MRI technology.
Clinical Focus
Medical conditions and clinical areas addressed by HeartVista.
Who It Serves
Milestones & Awards
Recent Milestones
Two-year data release proving faster and more reliable MRI scans (December 2024), Daniel Hawkins appointed as CEO (March 2024), Steve Cashman joined Board of Directors (September 2023)
Key Partnerships
Social & Media
Latest Updates
Overcoming Underutilization of Cardiac MRI (CMR): Q&A with Dr. Sean Hughes from Vanderbilt University Medical Center
The Future of Cardiac MRI: A Q&A with Dr. Raymond Kwong from Brigham & Women’s Hospital
Scaling MRI Capacity in 2026: A Strategic Guide for Imaging Directors
Whitepaper: How to Build a Business Case for Cardiac MRI (CMR) Adoption
Vista AI Secures $29.5M in Series B Funding as Health Systems Back Automated MRI Scanning
Company Details
- Founded
- 2012
- Headquarters
- Redwood City, CA, USA
- Employees
- 11-50
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.